- Home
- SMSI vs PLUR Comparison
SMSI vs PLUR Comparison
Compare SMSI & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMSI | PLUR |
|---|---|---|
| Founded | 1982 | 2001 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.7M | 18.5M |
| IPO Year | 2017 | 2001 |
Fundamental Metrics
Financial Performance| Metric | SMSI | PLUR |
|---|---|---|
| Price | $2.93 | $1.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 12.6K | ★ 26.4K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.94 | 31.46 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,363,000.00 | $1,016,000.00 |
| Revenue This Year | $13.97 | $97.38 |
| Revenue Next Year | $53.35 | $293.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.41 | $1.18 |
| 52 Week High | $6.13 | $4.96 |
Technical Indicators
Market Signals| Indicator | SMSI | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 31.58 |
| Support Level | $2.66 | N/A |
| Resistance Level | $3.03 | $1.85 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 18.16 | 2.04 |
Price Performance
Historical ComparisonAbout SMSI Smith Micro Software Inc.
Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.